Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates the safety, pharmacokinetics, and efficacy of KPL-404 in rheumatoid arthritis patients who have inadequate response or intolerance …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KPL-404

Snippet

Sponsor: Kiniksa Pharmaceuticals, Ltd. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2025-07-22